A synthetic peptide for use as a blocking control in assays to test for specificity of HBXIP antibody, Alternative Names: HBXIP control peptide, HBXIP antibody Blocking Peptide, Anti-HBXIP Blocking Peptide, Hepatitis B Virus X Interacting Protein Blocking Peptide, MGC71071 Blocking Peptide, XIP Blocking Peptide
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
HBXIP
(Hepatitis B Virus X-Interacting Protein (HBXIP))
Synonyme
HBXIP Peptide, xip Peptide, XIP Peptide, 1110003H18Rik Peptide, Hbxip Peptide, late endosomal/lysosomal adaptor, MAPK and MTOR activator 5 Peptide, Hepatitis B virus X-interacting protein Peptide, LAMTOR5 Peptide, xip Peptide, Lamtor5 Peptide
Substanzklasse
Viral Protein
Hintergrund
HBXIP is a protein that specifically complexes with the C-terminus of hepatitis B virus X protein (HBx). The function of this protein is to negatively regulate HBx activity and thus to alter the replication life cycle of the virus.